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parotid MALT lymphoma (Haacke et al., unpublished data) . In another recent study only 3/7 (43%) pSS patients with pulmonary MALT lymphomas exhibited MG (9) . Presence of MG is known as a risk factor for NHL development, but is also associated with higher disease activity (8, 10) . The presence of MG in pSS pre-lymphoma patients in the study of Sène et al. (1) , could thus also be a reflection of high disease activity (ESSDAI) which is an independent predictor for NHL development (11) .
Also the presence of GCs in biopsies is associated with high disease status (12) . Since disease activity as measured by ESSDAI can change over time, (13) the time point when the diagnostic pSS biopsy is taken, is of crucial importance. If a labial gland biopsy is taken during a period of relatively low disease activity, the likelihood of presence of GCs might consequently be low. On the other hand, when a diagnostic pSS salivary gland biopsy is taken in a period of high disease activity, the chance of finding GCs is higher.
Thus, both GCs and MG are associated with higher disease status, but there is no clear indication that presence of ectopic GCs is a prerequisite for MALT lymphoma development. There are many pSS patients with GCs in their salivary gland biopsies that do not develop NHL. Of note, presence of GCs is usually assessed in labial salivary glands, which are not the sites where MALT lymphoma preferentially develop. We conclude that for prediction of pSS patients who are at risk for NHL development, clinical and laboratory factors such as low C4, RF-positivity, presence of cryoglobulin, highly active disease, purpura, lymphadenopathy and especially persistent parotid enlargement (5, 11, 14) are more important than presence of GCs in diagnostic salivary gland biopsies.
